Tag: Deviation

Addressing Batch Execution with Expired SOP During Changeover: A Detailed Case Study In the fast-paced world of pharmaceutical manufacturing, stringent adherence to standard operating procedures (SOPs) is paramount for ensuring…

Breakdown of an FDA Inspection Observation Regarding An Unapproved Process Parameter Change In modern pharmaceutical manufacturing, compliance with regulatory standards is paramount, particularly during periods of external inspection. This case…

Case Study: Unapproved Process Changes in Routine Manufacturing Leading to FDA Inspection Findings In the rapidly evolving pharmaceutical landscape, stringent adherence to protocols is crucial for maintaining compliance and ensuring…

Understanding the Implications of Unapproved Process Changes During Routine Manufacturing In a recent case study, a pharmaceutical manufacturing facility faced significant challenges due to a process change that had been…

Addressing Recurrent Deviations in Batch Production During Technology Transfer The pharmaceutical industry faces numerous challenges, particularly during technology transfers that involve moving processes from one facility to another. A case…

Regulatory Impact Assessment of Equipment Utilized Without Release During Inspection Preparation Deviations in pharmaceutical manufacturing can lead to significant impacts on product quality, patient safety, and regulatory compliance. One crucial…

Addressing the Issue of Executing a Batch with an Expired SOP During Tech Transfer In a complex pharmaceutical manufacturing environment, maintaining compliance with Standard Operating Procedures (SOPs) is crucial. Executing…

Analyzing the Impact of Unapproved Process Changes During Changeover in Pharmaceutical Manufacturing In the highly regulated world of pharmaceutical manufacturing, the integrity of processes is paramount to ensure product quality…

Identifying and Addressing the Impact of Skipped IPCs During Scale-Up in Pharma Manufacturing In pharmaceutical manufacturing, adherence to in-process controls (IPCs) is paramount to ensure product integrity and compliance with…

Assessing the Impact of Unplanned Hold Time Extensions During Changeovers: A Case Study In the highly regulated environment of pharmaceutical manufacturing, unplanned hold time extensions during changeover processes can lead…

Analyzing an Unapproved Change in Process Parameters During a Commercial Campaign During a recent commercial-scale pharmaceutical manufacturing campaign, a significant deviation was detected involving an unapproved change in process parameters.…

Assessment of Unapproved Changes During Pharmaceutical Tech Transfer: A Case Study In the complex world of pharmaceutical manufacturing, deviations from established processes can lead to significant regulatory impacts and risks…